Satomi Niwayama

post-doc

You can help our author matching system! If you notice any publications incorrectly attributed to this author, please sign in and mark matches as correct or incorrect.
NIWAYAMA S, LOH C, TURK BE, et al. (2010) ChemInform Abstract: Enhanced Potency of Perfluorinated Thalidomide Derivatives for Inhibition of LPS-Induced Tumor Necrosis Factor-α Production is Associated with a Change of Mechanism of Action. Cheminform. 29: no-no
Niwayama S, Loh C, Turk BE, et al. (1998) Enhanced potency of perfluorinated thalidomide derivatives for inhibition of LPS-induced tumor necrosis factor-α production is associated with a change of mechanism of action Bioorganic and Medicinal Chemistry Letters. 8: 1071-1076
Griffith EC, Zhuang SU, Niwayama S, et al. (1998) Molecular recognition of angiogenesis inhibitors fumagillin and ovalicin by methionine aminopeptidase 2 Proceedings of the National Academy of Sciences of the United States of America. 95: 15183-15188
Miyachi H, Koiso Y, Shirai R, et al. (1998) Tumor necrosis factor-alpha production enhancing activity of substituted 3'-methylthalidomide: Influence of substituents at the phthaloyl moiety on the activity and stereoselectivity Chemical and Pharmaceutical Bulletin. 46: 1165-1168
Niwayama S, Turk BE, Liu JO. (1996) Potent inhibition of tumor necrosis factor-α production by tetrafluorothalidomide and tetrafluorophthalimides Journal of Medicinal Chemistry. 39: 3044-3045